Physician profile
Patrick M Verb
NPI 1992715247
$730.47
in general payments reported to CMS, 2019-2025
12 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.16 · 2020: $27.35 · 2022: $21.83 · 2023: $29.56 · 2024: $229 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $361.42 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Rocklatan |
| Abbvie INC. | $106.34 | 2024-2025 | |
| Oyster Point Pharma, INC. | $51.39 | 2022-2023 | Tyrvaya |
| Bausch & Lomb Americas INC. | $42.74 | 2025 | Xiidra, Miebo |
| Allergan, INC. | $27.35 | 2020 | |
| Sun Pharmaceutical Industries INC. | $25.34 | 2025 | |
| Genentech USA, INC. | $24.99 | 2025 | Vabysmo |
| Mallinckrodt Hospital Products INC. | $23.75 | 2024 | Acthar |
| Astellas Pharma US INC | $18.07 | 2024 | Izervay |
| Sight Sciences, INC. | $17.93 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Thea Pharma INC. | $17.29 | 2024 | Iyuzeh |
| Amgen INC. | $13.86 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Verb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.